Jackson Creek Investment Advisors LLC Nurix Therapeutics, Inc. Transaction History

Jackson Creek Investment Advisors LLC

  • $338 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 03, 2023
SELL
$9.86 - $14.59 $52,386 - $77,516
-5,313 Reduced 9.66%
49,662 $545,000
Q3 2022

Nov 09, 2022
SELL
$12.33 - $19.81 $1,011 - $1,624
-82 Reduced 0.15%
54,975 $716,000
Q2 2022

Aug 04, 2022
BUY
$7.88 - $14.82 $433,849 - $815,944
55,057 New
55,057 $879,000

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $1.04B
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Jackson Creek Investment Advisors LLC Portfolio

Follow Jackson Creek Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jackson Creek Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jackson Creek Investment Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email